A detailed history of Keebeck Alpha, LP transactions in Personalis, Inc. stock. As of the latest transaction made, Keebeck Alpha, LP holds 10,284 shares of PSNL stock, worth $50,494. This represents 0.06% of its overall portfolio holdings.

Number of Shares
10,284
Holding current value
$50,494
% of portfolio
0.06%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 03, 2025

BUY
$3.38 - $6.26 $34,759 - $64,377
10,284 New
10,284 $59,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $225M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Keebeck Alpha, LP Portfolio

Follow Keebeck Alpha, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keebeck Alpha, LP, based on Form 13F filings with the SEC.

News

Stay updated on Keebeck Alpha, LP with notifications on news.